TD Cowen raises target for HCA Healthcare stock to USD 460 from USD 431?.,

Published on 10/16/2026 at 10:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 20.23 billion, up 8.70 percent. HCA Healthcare stock costs EUR 418.75 on October 16, 2026.

Catalyst and market markers

TD Cowen raised its HCA Healthcare target from USD 431 to USD 460 on October 12, 2026.
Second-quarter revenue reached USD 20.23 billion, up 8.70 percent.
HCA Healthcare stock trades at EUR 418.75 at 10:32 a.m. CEST at Lang & Schwarz on October 16, 2026.

Fotorealistisches Krankenhaus-Außengebäude mit Ambulanzen am Haupteingang bei Sonnenuntergang — HCA Healthcare US40412C1018 zeigt einen modernen Krankenhaus Campus mit Notaufnahme bei goldenem Abendlicht, Illustration mit AI erstellt.

HCA Healthcare raised its investment case after Markets Insider reported on October 12, 2026, that TD Cowen lifted its price target from USD 431 to USD 460 while retaining a Buy rating. HCA Healthcare stock was trading at EUR 418.75 at Lang & Schwarz on October 16, 2026 at 10:32 a.m. CEST.

Target rises before results

TD Cowen lowered its third-quarter adjusted EBITDA estimate because of weaker hospital survey results, but raised its fourth-quarter estimate on expected cost reductions, according to the same October 12 report. The target change therefore combines a near-term operating caution with a more constructive view of cost control.

HCA Healthcare's second-quarter revenue reached USD 20.23 billion, while adjusted earnings were USD 7.59 per share. Investing.com reported on September 22, 2026, that revenue exceeded a USD 19.38 billion estimate and adjusted earnings exceeded a USD 7.40 estimate. Revenue was 8.70 percent higher than in the comparable period.

Three events shape the story

On July 24, 2026, HCA Healthcare reported second-quarter revenue of USD 20.23 billion and adjusted earnings of USD 7.59 per share, according to MarketBeat. On September 22, BMO Capital began coverage with an Outperform rating and a USD 495 target, as reported by Investing.com. On October 12, TD Cowen raised its target from USD 431 to USD 460.

What date comes next?

HCA Healthcare scheduled its third-quarter 2026 earnings call for October 27, 2026, at 10:00 a.m. Eastern time, according to the company's investor-relations release dated September 30, 2026. The call is the next dated catalyst for the stock and will test whether the cost reductions reflected in TD Cowen's updated estimate appear in reported results.

Valuation meets the next catalyst

HCA Healthcare had a market capitalization of USD 101.4 billion as of October 15, 2026. Its 52-week range was USD 353.99 to USD 556.52, placing the latest US quote within a broad valuation frame while the October 27 reporting date approaches.

HCA Healthcare was trading at EUR 418.75 at Lang & Schwarz on October 16, 2026 at 10:32 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of HCA Healthcare stock.